Bradley J. Monk, MD, FACOG, FACS | Authors


Key Takeaways from the OUTBACK Trial of Adjuvant Chemotherapy in Cervical Cancer

July 23, 2022

Bradley Monk, MD, FACCOG, FACS, discusses main takeaways from the OUTBACK trial of adjuvant chemotherapy following chemoradiation as primary treatment in patients with locally advanced cervical cancer vs chemoradiation alone.